?? Happy Thanksgiving from Duke Eye Center! ??
Duke Eye Center
医疗机构
Durham,North Carolina 3,932 位关注者
Duke Eye Center is a leader in research, education and patient care; dedicated to curing eye disease worldwide.
关于我们
Duke Eye Center is an internationally-renowned academic medical institution dedicated to curing eye disease worldwide though excellence in research, education, and patient care. Specializing in all areas of ophthalmology, it is a top ranked program by the US News and World Report Best Hospitals survey for 30 years.
- 网站
-
https://dukeeye.org
Duke Eye Center的外部链接
- 所属行业
- 医疗机构
- 规模
- 501-1,000 人
- 总部
- Durham,North Carolina
- 类型
- 非营利机构
- 创立
- 1965
- 领域
- Cornea、Glaucoma、Ophthalmology、Ocular Immunology、Ophthalmic Oncology、Retinal Genetics、Surgical Retina、Medical Retina、Cataracts、Comprehensive Ophthalmology、Pediatric Ophthalmology、Vision Rehabilitation、Refractive Surgery、Oculofacial Surgery、Pediatric Retina and Optic Nerve和Ophtalmology Research
地点
Duke Eye Center员工
动态
-
In this season of Thanksgiving, we express our gratitude not only for the opportunity to care for our patients but also for the inspiration they provide for our research. Sharon Fekrat MD FACS FASRS and her patient, Mrs. Scott E. Hughes, exemplify this sentiment. Mrs. Hughes and her?identical?twin sister?inspired Fekrat's iMIND research group after?Mrs. Hughes sister developed Alzheimer's disease while she?did not. Intrigued by this difference, Fekrat performed an Optical Coherence Tomography (OCT)?and OCT angiography imaging?on both sisters and discovered significantly different results. ? The iMIND group, which stands for Eye Multimodal Imaging in Neurodegenerative Disease, has found that by imaging retinal tissue using noninvasive?and widely available imaging cameras, it may be possible to detect various neurodegenerative conditions?in the retina?before symptoms appear and?may?confirm accurate diagnoses earlier in the disease continuum. ? Mrs. Hughes is now 103 years old, while her twin sister passed away several years ago?from Alzheimer's. We extend our heartfelt thanks to all the patients who have inspired research at Duke and beyond. We are truly grateful for you. Duke Health Duke University School of Medicine
-
Find out what caused endogenous endophthalmitis in this patient in our incredible new case report! #DJCRO Janiece Rosado, M.A., Melissa Yuan MD, Dan Gong MD https://lnkd.in/gs58pwBT #ophthalmology #research #medicine Massachusetts Eye and Ear
-
We were honored to collaborate with the Singapore National Eye Centre (SNEC) to launch the Duke-SNEC Fellows Advanced Vitreous Surgery (fAVS) Course. This inaugural event brought together distinguished faculty from both institutions, including course directors Dr. Andrew Tsai and Dr. Farah Ibrahim from SNEC, and course advisors Dr. Gemmy Cheung (SNEC) and Dr. Lejla Vajzovic, MD, FASRS. Duke faculty members Dr. Dilraj Grewal, MD, FASRS, Dr. Majda Hadziahmetovic, and Dr. Glenn Jaffe also shared their expertise, joined by Duke Vitreoretinal Surgery Fellow Dr. Tammy Hsu and Duke University School of Medicine Student Lindsey Chew. This international gathering featured dynamic lectures, interactive panel discussions, and updates on key medical retina conditions. With 60 participants from 15 countries, the Duke-SNEC fAVS Course showcased advanced vitreoretinal surgical techniques through hands-on wet-lab sessions and fostered meaningful collaborations within the global retina community. After successfully hosting the Duke fAVS Course in the U.S. for 11 years, we are excited to expand this initiative internationally with our SNEC colleagues. Together, we remain committed to advancing knowledge, innovation, and partnerships in retina surgery!
-
+1
-
Majda Hadziahmetovic, MD, served as the Lead Principal Investigator on a Phase 1 clinical trial that is showing promising results for patients with geographic atrophy. The trial demonstrated reduced lesion growth, preservation of retinal tissue, and improved visual function. This novel gene therapy could be a game-changer for patients with dry age-related macular degeneration. Read more: https://lnkd.in/egrPeN3W
-
Durga S. Borkar, MD, MMCi explores the expanded potential of complement inhibitor treatments in ophthalmology and shares how these advancements could impact patient care and outcomes in recent Retina Today article. Read more: https://lnkd.in/gWq5XNC9
Expanding GA treatment is key, but balancing early intervention with adherence is challenging. Complement inhibitors show promise, yet need long-term commitment. Patient education & imaging can help clinicians find those who benefit most. #GeographicAtrophy https://bit.ly/4fXqhJT
-
A Duke School of medicine led study shows the ways doctors predict glaucoma risk are less effective for Black patients, even though glaucoma is more common and severe in those of African descent. The problem may be in the design of the polygenic risk scores that mostly rely on data from European and Asian populations, and researchers found the models work well for Europeans. The blind spot in prediction for Black patients could deepen health disparities and delay treatment to protect their eyesight. “These predictive gaps mean that Black patients may not be accurately classified into high-risk categories for primary open angle glaucoma,” said co-first study author Jennifer M. Chang-Wolf, MD, a Duke University School of Medicine graduate who conducted research with the Duke Department of Ophthalmology. “This can result in fewer early interventions or preventative strategies for those who need them most.” Duke Eye Center #glaucoma https://lnkd.in/evjcVptU
-
Congratulations to Madison Dunning, OD and Qiaohui Wei White, OD for achieving their Fellowship of the American Academy Of Optometry (FAAO). This accomplishment highlights their dedication to the highest standards of optometric care, evidence-based practice, and lifelong learning. The rigorous process included research, literature review, and the completion of written case reports, culminating in an oral exam before a subcommittee of peers.
-
Join Us for Vision Quest 2025! This in-person meeting is designed to update allied ophthalmic personnel on the latest advancements and new technologies in ophthalmology. Earn?7 JCAHPO CE credits?while enhancing your skills! ???Date:?January 25, 2025???Location:?Duke Eye Center, AERI Auditorium ???Register Now:?https://lnkd.in/exH-XDcS
此处无法显示此内容
在领英 APP 中访问此内容等
-
Last night we were thrilled to host the Mittra Family Foundation Lecture featuring our distinguished guest lecturer, Prithvi Mruthyunjaya, MD,MHS, Professor of Ophthalmology and, by courtesy, of Radiation Oncology from Byers Eye Institute at Stanford. Dr. Mruthyunjaya, a proud Duke Eye Center alumnus, completed his ophthalmology residency and vitreoretinal fellowship here, and served as a faculty member for 15 years, where he established the ocular oncology division.